Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
7/17/2024 | $555.00 → $615.00 | Outperform | RBC Capital Mkts | |
7/17/2024 | $481.00 → $647.00 | Hold → Buy | Jefferies | |
6/26/2024 | $392.00 | Overweight | Piper Sandler | |
6/26/2024 | $400.00 | Overweight | Piper Sandler | |
6/24/2024 | $374.00 | Equal-Weight | Morgan Stanley | |
6/5/2024 | $580.00 | Hold → Buy | HSBC Securities | |
5/30/2024 | $597.00 | Outperform | Robert W. Baird | |
5/30/2024 | $61.00 | Neutral | Robert W. Baird |
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)
144 - Cigna Group (0001739940) (Subject)
144 - Cigna Group (0001739940) (Subject)
144 - Cigna Group (0001739940) (Subject)
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on October 25, 2024 to stockholders of record as of the close of business on September 30, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, mil
AM Best has revised the outlook to stable from positive for the Long-Term Issuer Credit Rating (Long-Term ICR) and affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term ICRs of "a" (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of CVS Health Corporation (CVS Health) (NYSE:CVS). The outlook of the FSR is stable. (Please see below for a detailed listing of the companies.) The Credit Ratings (ratings) of Aetna Health & Life Group reflect its balance sheet strength, which AM Best assesses as very strong, as well as it
The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.10 per share, to be paid on September 24, 2024, to all shareholders of record of UNH common stock as of the close of business September 16, 2024. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range o
Humana Inc. (NYSE:HUM) announced today that Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at the Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 8:00 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana's Investor Relations page at humana.com. The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to allow time to run a system test and download any free software needed for access purposes. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, an
Humana Inc. (NYSE:HUM), a leading health and well-being company, launches a refreshed military-connected hiring strategy and earns recognition by U.S. Veterans Magazine as a Top Veteran-Friendly Employer and Top Veteran-Friendly Supplier Diversity Program. Humana administers health benefits for nearly 6 million active-duty military and retirees nationwide and understands the importance of a workforce that reflects the diversity of the military and veteran communities it serves. Humana introduced its initial veteran and military-connected hiring strategy in 2011 and, to date, has hired approximately 6,000 veterans and military spouses. To keep pace with the current needs of veterans and mi
BLOOMFIELD, Conn., Aug. 15, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that David Cordani, Chairman and Chief Executive Officer, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, in New York, NY. The Cigna Group's presentation is expected to begin at approximately 10:45 a.m. ET. A live webcast of the presentation will be available at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of The Cigna Group's website. To listen to this p
WOONSOCKET, R.I., Aug. 14, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Heidi Capozzi will join the company as Executive Vice President, Chief People Officer, effective September 9. She will lead the human resources, labor relations, compensation and benefits, and corporate social responsibility teams who support CVS Health's strategy to build a world of health around every consumer. "Heidi brings a depth of experience and a breadth of industry insights to CVS Health, in particular a proven track record of hiring, building, and growing strong teams and adv
David Dintenfass to lead new centralized function focused on customer experience, sales and marketing Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today that it has named David Dintenfass as President of Enterprise Growth. In this new role, Dintenfass will have responsibility for leading the company's growth plan with a primary focus on customer acquisition, retention, and experience. The creation of this position, and its emphasis on the customer and digital experience, will help Humana deliver on its long-term strategy and maximize long-term growth within the Medicare Advantage market. By 2030, one in five Americans is projected to be 65 years
Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna HealthcareAnn Dennison to join The Cigna Group as Deputy Chief Financial OfficerMike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna HealthcareEric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health ServicesBLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.
RBC Capital Mkts reiterated coverage of UnitedHealth with a rating of Outperform and set a new price target of $615.00 from $555.00 previously
Jefferies upgraded UnitedHealth from Hold to Buy and set a new price target of $647.00 from $481.00 previously
Piper Sandler initiated coverage of Humana with a rating of Overweight and set a new price target of $392.00
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
Builds On Ongoing Collaboration With Google Health To Develop Population Health Solutions And Address Healthcare Challenges
UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 5 years by 4.56% on an annualized basis producing an average annual return of 17.03%. Currently, UnitedHealth Group has a market capitalization of $515.19 billion. Buying $1000 In UNH: If an investor had bought $1000 of UNH stock 5 years ago, it would be worth $2,205.30 today based on a price of $559.75 for UNH at the time of writing. UnitedHealth Group's Performance Over Last 5 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automa
TD Cowen analyst Gary Taylor maintains Humana (NYSE:HUM) with a Buy and raises the price target from $396 to $407.